Deferasirox for patients with advanced hepatocellular carcinoma : pilot study
Not Applicable
- Conditions
- advanced hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000013451
- Lead Sponsor
- Yamaguchi University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1) Severe coexisting illness (expect for chronic hepatitis or liver cirrhosis) 2) Active double cancers 3) Past history of hypersensitivity for drugs including iodine and contrast agent 4) Patients with pregnancy, lactation or possibility of pregnancy 5) Past history of interstitial pneumonia 6) Chronic respiratory failure 7) Patients who judged as inadequacy due to other reasons by the doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method Survival, Response, Progression-free survival